Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial

Etude concernée: IFCT-1602
Auteurs / Authors: A. Lavole, J. Mazieres, S. Schneider, S. Brosseau, L.M. Kiakouama, L. Greillier, A. Guihot, B. Abbar, M. Baron, A. Makinson, A. Langlais, F. Morin, J-P. Spano, J. Cadranel
Journal / Conference: Lung Cancer
Année / Year: 2021
Lien vers la publication: https://www.sciencedirect.com/science/article/abs/pii/S0169500221004116